Statistics

Total Visits

Views
Bevacizumab intravitreo como tratamiento de las telangiectasias yuxtafoveales idiopaticas tipo i18

Select a period of time:

Number of views in the range

Views
Bevacizumab intravitreo como tratamiento de las telangiectasias yuxtafoveales idiopaticas tipo i9

Views

Views
May 20245
June 20242
July 20240
August 20241
September 20241
October 20240
November 20240
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States9
 

Top cities views

Views
Chicago2